Opinion statement
Evidence-based treatment algorithms are needed for managing headache during conception, pregnancy, and the postpartum period. Whereas most studies seem to indicate that headaches improve for most women during pregnancy (as estrogen levels increase), this often is not the case in women with more severe, frequent migraine. Few pharmacologic studies include pregnant women, so evidence-based treatments are lacking. Pregnancy registries to record adverse outcomes for various medications and large, population-based studies are needed to analyze the behavior of chronic headache, particularly chronic migraine, during pregnancy. Collaboration between headache specialists and obstetricians is needed to promote research and education for the optimal management of headache during pregnancy.
Similar content being viewed by others
References and Recommended Reading
Brandes JL: The influence of estrogen on migraine: a systematic review. JAMA 2006, 295:1824–1830.
Sances G, Granella F, Nappi RE, et al.: Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003, 23:197–205.
Marcus DA, Scharff L, Turk D: Longitudinal prospective study of headache during pregnancy and postpartum. Headache 1999, 39:625–632.
Scharff L, Marcus DA, Turk DC: Headache during pregnancy and in the postpartum: a prospective study. Headache 1997, 37:203–210.
Somerville BW: A study of migraine in pregnancy. Neurology 1972, 22:824–828.
Wall VR: Breastfeeding and migraine headaches. J Hum Lact 1992, 8:209–212.
Rasmussen BK: Migraine and tension-type headache in a general population: Precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993, 53:65–72.
Wainscott G, Sullivan FM, Volans GN, Wilkinson M: The outcome of pregnancy in women suffering from migraine. Postgrad Med J 1978, 54:98–102.
Aube M: Migraine in pregnancy. Neurology 1999, 53:S26–S28.
Ertresvg JM, Stovner LJ, Kvavik LE, et al.: Migraine aura or transient ischemic attacks? A five-year follow-up case-control study of women with transient central nervous system disorders in pregnancy. BMC Med 2007, 5:19.
Silberstein SD: Migraine and pregnancy. Neurol Clin 1997, 15:209–231.
Marcus DA: Pregnancy and chronic headache. Expert Opin Pharmacother 2002, 3:389–393.
Gülmezoglu AM, Hofmeyr GJ: Calcium channel blockers for potential impaired fetal growth. Cochrane Database Syst Rev 2000, 2:CD000049.
Sorensen HT, Czeizel AE, Rockenbauer M, et al.: The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers. Acta Obstet Gynecol Scand 2001, 80:397–401.
Palmieri C, Canger R: Teratogenic potential of the newer antiepileptic drugs: what is known and how should this influence prescribing? CNS Drugs 2002, 16:755–764.
Thomas SV, Indrani L, Devi GC, et al.: Pregnancy in women with epilepsy: preliminary results of kerala registry of epilepsy and pregnancy. Neurol India 2001, 49:60–66.
Topiramate (prescribing information). In Physicians’ Desk Reference 2006. Montvale, NJ: Thomson Healthcare; 2006:2442.
Bigal ME, Lipton RB: Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 2006, 67:252–257.
Carp HJ, Fein A, Nebel L: Effect of diclofenac on implantation and embryonic development in the rat. Eur J Obstet Gynecol Reprod Biol 1988, 28:273–277.
Kanayama K, Osada H, Nariai K, Endo T: Inhibitory effects of indomethacin on implantation and its related phenomena. J Int Med Res 1996, 24:358–362.
Momma K, Uemura S, Nishihara S, Ota Y: Dilatation of the ductus arteriosus by prostaglandins and prostaglandin’s precursors. Pediatr Res 1980, 14:1074–1077.
Rein AJ, Nadjari M, Elchalal U, Nir A: Contraction of the fetal ductus arteriosus induced by diclofenac. Case report. Fetal Diagn Ther 1999, 14:24–25.
Morris JL, Rosen DA, Rosen KR: Nonsteroidal anti-inflammatory agents in neonates. Paediatr Drugs 2003, 5:385–405.
Stein GS: Headaches in the first post partum week and their relationship to migraine. Headache 1981, 21:201–205.
Stein G, Morton J, Marsh A, et al.: Headaches after childbirth. Acta Neurol Scand 1984, 69:74–79.
Granella F, Sances G, Zanferrari C, et al.: Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993, 33:385–389.
American Academy of Pediatrics Committee on Drugs: The transfer of drugs and other chemicals into human milk. Pediatrics 2001, 108:776–789.
Simpkins JW, Field FP, Torosian G, Soltis EE: Effects of prenatal exposure to tricyclic antidepressants on adrenergic responses in progeny. Dev Pharmacol Ther 1985, 8:17–33.
Diekman MA, Green ML: Mycotoxins and reproduction in domestic livestock. J Anim Sci 1992, 70:1615–1627.
Baskett TF: A flux of reds: evolution of active management of the third stage of labor. J R Soc Med 2000, 93:489–493.
Briggs GG, Freeman RK, Yaffe SJ: Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risks, edn 5. Baltimore, MD: Williams & Wilkins; 1998.
Friedman JM, Polifka JE: TERIS. Micromedex Reproductive Risk Information System (REPRORISK). Englewood, CO: Thomson MICROMEDEX; 2001.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brandes, J.L. Headache related to pregnancy: Management of migraine and migraine headache in pregnancy. Curr Treat Options Neurol 10, 12–19 (2008). https://doi.org/10.1007/s11940-008-0002-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11940-008-0002-4